市場調査レポート
商品コード
1083084

モンテルカストナトリウムの世界市場:2022年~2026年

Global Montelukast Sodium Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
モンテルカストナトリウムの世界市場:2022年~2026年
出版日: 2022年05月29日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のモンテルカストナトリウムの市場規模は、2022年~2026年の間に18億8,000万米ドルの増加が見込まれ、予測期間中にCAGRで6.1%の成長が予測されています。

市場は、喘息治療薬に対する需要の増加、患者の意識の向上、強力なパイプラインと新薬の承認によって牽引されています。

当レポートでは、世界のモンテルカストナトリウム市場について調査分析し、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • サプライヤーの交渉力
  • 新興企業の脅威
  • 代替品の脅威
  • 競合企業の脅威
  • 市況

第5章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • タブレット - 市場規模と予測:2021年~2026年
  • チュアブル錠 - 市場規模と予測:2021年~2026年
  • 経口ソリューション - 市場規模と予測:2021年~2026年
  • 市場機会:タイプ別

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 - 市場規模と予測:2021年~2026年
  • 欧州 - 市場規模と予測:2021年~2026年
  • アジア太平洋 - 市場規模と予測:2021年~2026年
  • その他の地域(ROW) - 市場規模と予測:2021年~2026年
  • 米国 - 市場規模と予測:2021年~2026年
  • 中国 - 市場規模と予測:2021年~2026年
  • ドイツ - 市場規模と予測:2021年~2026年
  • カナダ - 市場規模と予測:2021年~2026年
  • 英国 - 市場規模と予測:2021年~2026年
  • 市場機会:地域情勢別

第8章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Jubilant Pharmova Ltd.
  • Merck and Co. Inc.
  • Morepen Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

第11章 付録

目次
Product Code: IRTNTR73545

Technavio has been monitoring the montelukast sodium market and it is poised to grow by $ 1.88 billion during 2022-2026, accelerating at a CAGR of 6.1% during the forecast period. Our report on the montelukast sodium market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for asthma medications, an increase in patient awareness, and a strong pipeline and new drug approvals.

The montelukast sodium market analysis includes type segment and geographic landscape.

Technavio's montelukast sodium market is segmented as below:

By Type

  • Tablets
  • Chewable tablets
  • Oral solutions

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • Rest of World (ROW)

This study identifies the patient assistance initiatives by governments and advocacy groups as one of the prime reasons driving the montelukast sodium market growth during the next few years. Also, an increase in collaborations and expanding research in curative approaches will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the montelukast sodium market covers the following areas:

  • Montelukast sodium market sizing
  • Montelukast sodium market forecast
  • Montelukast sodium market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading montelukast sodium market vendors that include Apotex Inc., Aurobindo Pharma Ltd., Bio-Techne Corp., Cayman Chemical Co., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Hetero Healthcare Ltd., Hikma Pharmaceuticals Plc, Jubilant Pharmova Ltd., Krosyl Pharmaceuticals Pvt. Ltd., Merck and Co. Inc., Morepen Laboratories Ltd., Novartis AG, Simson Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., Unimark Remedies Ltd., and Viatris Inc. Also, the montelukast sodium market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Tablets - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Tablets - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Tablets - Year-over-year growth 2021-2026 (%)
  • 5.4 Chewable tablets - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Chewable tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Chewable tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Chewable tablets - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Chewable tablets - Year-over-year growth 2021-2026 (%)
  • 5.5 Oral solutions - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Oral solutions - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Oral solutions - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Oral solutions - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Oral solutions - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Type
  • Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 APAC - Market size and forecast 2021-2026
  • Exhibit 54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 UK - Market size and forecast 2021-2026
  • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Apotex Inc.
  • Exhibit 89: Apotex Inc. - Overview
  • Exhibit 90: Apotex Inc. - Product / Service
  • Exhibit 91: Apotex Inc. - Key offerings
  • 10.4 Aurobindo Pharma Ltd.
  • Exhibit 92: Aurobindo Pharma Ltd. - Overview
  • Exhibit 93: Aurobindo Pharma Ltd. - Product / Service
  • Exhibit 94: Aurobindo Pharma Ltd. - Key offerings
  • 10.5 Cipla Ltd.
  • Exhibit 95: Cipla Ltd. - Overview
  • Exhibit 96: Cipla Ltd. - Business segments
  • Exhibit 97: Cipla Ltd. - Key news
  • Exhibit 98: Cipla Ltd. - Key offerings
  • Exhibit 99: Cipla Ltd. - Segment focus
  • 10.6 Glenmark Pharmaceuticals Ltd.
  • Exhibit 100: Glenmark Pharmaceuticals Ltd. - Overview
  • Exhibit 101: Glenmark Pharmaceuticals Ltd. - Product / Service
  • Exhibit 102: Glenmark Pharmaceuticals Ltd. - Key offerings
  • 10.7 Jubilant Pharmova Ltd.
  • Exhibit 103: Jubilant Pharmova Ltd. - Overview
  • Exhibit 104: Jubilant Pharmova Ltd. - Business segments
  • Exhibit 105: Jubilant Pharmova Ltd. - Key news
  • Exhibit 106: Jubilant Pharmova Ltd. - Key offerings
  • Exhibit 107: Jubilant Pharmova Ltd. - Segment focus
  • 10.8 Merck and Co. Inc.
  • Exhibit 108: Merck and Co. Inc. - Overview
  • Exhibit 109: Merck and Co. Inc. - Business segments
  • Exhibit 110: Merck and Co. Inc. - Key news
  • Exhibit 111: Merck and Co. Inc. - Key offerings
  • Exhibit 112: Merck and Co. Inc. - Segment focus
  • 10.9 Morepen Laboratories Ltd.
  • Exhibit 113: Morepen Laboratories Ltd. - Overview
  • Exhibit 114: Morepen Laboratories Ltd. - Key offerings
  • 10.10 Sun Pharmaceutical Industries Ltd.
  • Exhibit 115: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 116: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 117: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 10.11 Teva Pharmaceutical Industries Ltd.
  • Exhibit 118: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 119: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 120: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 122: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 10.12 Viatris Inc.
  • Exhibit 123: Viatris Inc. - Overview
  • Exhibit 124: Viatris Inc. - Business segments
  • Exhibit 125: Viatris Inc. - Key offerings
  • Exhibit 126: Viatris Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 127: Inclusions checklist
  • Exhibit 128: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 129: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 130: Research methodology
  • Exhibit 131: Validation techniques employed for market sizing
  • Exhibit 132: Information sources
  • 11.5 List of abbreviations
  • Exhibit 133: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Tablets - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Tablets - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Chewable tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Chewable tablets - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Chewable tablets - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Chewable tablets - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Oral solutions - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Oral solutions - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Oral solutions - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Oral solutions - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Type ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Apotex Inc. - Overview
  • Exhibits90: Apotex Inc. - Product / Service
  • Exhibits91: Apotex Inc. - Key offerings
  • Exhibits92: Aurobindo Pharma Ltd. - Overview
  • Exhibits93: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits94: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits95: Cipla Ltd. - Overview
  • Exhibits96: Cipla Ltd. - Business segments
  • Exhibits97: Cipla Ltd. - Key news
  • Exhibits98: Cipla Ltd. - Key offerings
  • Exhibits99: Cipla Ltd. - Segment focus
  • Exhibits100: Glenmark Pharmaceuticals Ltd. - Overview
  • Exhibits101: Glenmark Pharmaceuticals Ltd. - Product / Service
  • Exhibits102: Glenmark Pharmaceuticals Ltd. - Key offerings
  • Exhibits103: Jubilant Pharmova Ltd. - Overview
  • Exhibits104: Jubilant Pharmova Ltd. - Business segments
  • Exhibits105: Jubilant Pharmova Ltd. - Key news
  • Exhibits106: Jubilant Pharmova Ltd. - Key offerings
  • Exhibits107: Jubilant Pharmova Ltd. - Segment focus
  • Exhibits108: Merck and Co. Inc. - Overview
  • Exhibits109: Merck and Co. Inc. - Business segments
  • Exhibits110: Merck and Co. Inc. - Key news
  • Exhibits111: Merck and Co. Inc. - Key offerings
  • Exhibits112: Merck and Co. Inc. - Segment focus
  • Exhibits113: Morepen Laboratories Ltd. - Overview
  • Exhibits114: Morepen Laboratories Ltd. - Key offerings
  • Exhibits115: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits116: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits117: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits118: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits119: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits120: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits121: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits122: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits123: Viatris Inc. - Overview
  • Exhibits124: Viatris Inc. - Business segments
  • Exhibits125: Viatris Inc. - Key offerings
  • Exhibits126: Viatris Inc. - Segment focus
  • Exhibits127: Inclusions checklist
  • Exhibits128: Exclusions checklist
  • Exhibits129: Currency conversion rates for US$
  • Exhibits130: Research methodology
  • Exhibits131: Validation techniques employed for market sizing
  • Exhibits132: Information sources
  • Exhibits133: List of abbreviations